Reference
Product information updates recommended by Pharmacovigilance Risk Assessment Committee HPRA Drug Safety Newsletter : No. 112, et al. Jun 2023. Available from: URL: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/hpra-drug-safety-newsletter-edition-112.pdf?sfvrsn=5
Rights and permissions
About this article
Cite this article
PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib. Reactions Weekly 1962, 7 (2023). https://doi.org/10.1007/s40278-023-41677-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41677-0